- Home
- TTP vs OVID Comparison
TTP vs OVID Comparison
Compare TTP & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTP
- OVID
- Stock Information
- Founded
- TTP 2011
- OVID 2014
- Country
- TTP United States
- OVID United States
- Employees
- TTP N/A
- OVID N/A
- Industry
- TTP Trusts Except Educational Religious and Charitable
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- TTP Finance
- OVID Health Care
- Exchange
- TTP Nasdaq
- OVID Nasdaq
- Market Cap
- TTP 97.3M
- OVID 85.2M
- IPO Year
- TTP N/A
- OVID 2017
- Fundamental
- Price
- TTP $51.94
- OVID $1.06
- Analyst Decision
- TTP
- OVID Strong Buy
- Analyst Count
- TTP 0
- OVID 5
- Target Price
- TTP N/A
- OVID $4.04
- AVG Volume (30 Days)
- TTP 8.4K
- OVID 248.3K
- Earning Date
- TTP 01-01-0001
- OVID 11-12-2024
- Dividend Yield
- TTP 7.61%
- OVID N/A
- EPS Growth
- TTP N/A
- OVID N/A
- EPS
- TTP N/A
- OVID N/A
- Revenue
- TTP N/A
- OVID $631,695.00
- Revenue This Year
- TTP N/A
- OVID $21.51
- Revenue Next Year
- TTP N/A
- OVID $7,300.79
- P/E Ratio
- TTP N/A
- OVID N/A
- Revenue Growth
- TTP N/A
- OVID 113.21
- 52 Week Low
- TTP $24.75
- OVID $0.68
- 52 Week High
- TTP $31.22
- OVID $4.10
- Technical
- Relative Strength Index (RSI)
- TTP 87.77
- OVID 34.14
- Support Level
- TTP $49.00
- OVID $0.99
- Resistance Level
- TTP $50.78
- OVID $1.47
- Average True Range (ATR)
- TTP 1.18
- OVID 0.11
- MACD
- TTP 0.36
- OVID -0.03
- Stochastic Oscillator
- TTP 98.78
- OVID 4.56
About TTP Tortoise Pipeline & Energy Fund Inc.
Tortoise Pipeline & Energy Fund Inc is a non-diversified, closed-end investment management company. It invests in equity securities of North American pipeline companies that transport natural gas, natural gas liquids, crude oil, and refined products. The company seeks to invest in fixed-income and dividend-paying equity securities of power and energy infrastructure companies that provide stable and defensive characteristics throughout economic cycles.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.